Kadcyla 160 MG vials
Ended Awarded
- Contract number
- SPE2DB25FL1P6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $50,914
Award facts
- Contract value 100% obligated
- $50,913.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $50,913.84 to DMS Pharmaceutical Group Inc. for the supply of Kadcyla 160 mg vials. The award, issued on July 22, 2025, with an ultimate completion date of August 12, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The IDC enables the agency to procure a comprehensive range of pharmaceutical products to support medical supply needs across Department of Defense healthcare facilities. Kadcyla, a targeted cancer therapy, aligns with the company's established portfolio of delivering specialized pharmaceutical products including oncology treatments and biologics to military health systems. As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group continues to leverage its woman-owned small business status to provide direct distribution of prescription drugs and pharmacy services to DoD healthcare sites nationwide.
Quick answers
Who was awarded contract SPE2DB25FL1P6?
SPE2DB25FL1P6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 22, 2025.
How much is contract SPE2DB25FL1P6 worth?
The government has obligated $50,914 on SPE2DB25FL1P6.
Is contract SPE2DB25FL1P6 an order under another contract?
Yes. SPE2DB25FL1P6 is a delivery order under SPE2DB20D9331, an indefinite delivery contract.
Was contract SPE2DB25FL1P6 competed?
The extent of competition for SPE2DB25FL1P6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award